Prescriptions for Eli Lilly’s new weight-loss drug get off to a strong start and confirm bright outlook
[ad_1] The launch of Eli Lilly ‘s weight-loss drug Zepbound — a key pillar of our investment thesis in the pharmaceuticals giant — is going swimmingly in the U.S., Jefferies … Read More